FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing crystalline form A of a compound of formula (I), which is characterized by a powder X-ray diffraction pattern containing characteristic diffraction peaks at the following angle θ: 6.30±0.20°, 9.30±0.20°, 9.84±0.20°, 18.68±0.20°, 20.16±0.20°, 23.06±0.20°, 24.00±0.20° and 25.38±0.20°. Method involves adding a compound of formula (I) in any form to methanol, acetone, ethyl acetate, acetonitrile, an acetonitrile-water mixture at ratio of 1:1 or a mixture of acetone-water at ratio of 1:1, mixing mixture for 1 to 72 hours at temperature of 25 to 65°C. Mixture is then cooled to room temperature, filtered and the precipitate is dried on the filter to obtain crystalline form A. Weight ratio of the compound of formula (I) to the solvent is selected from 1:1–30.
EFFECT: obtaining crystalline form A of the compound of formula (I), characterized by good physical stability and chemical stability.
9 cl, 4 dwg, 8 tbl, 6 ex
Title |
Year |
Author |
Number |
CRYSTALLINE FORM OF A TRICYCLIC COMPOUND AND APPLICATION THEREOF |
2019 |
- Wang, Jing
- Jiang, Zhigan
- He, Haiying
- Yang, Yaxun
|
RU2775753C1 |
CRYSTAL FORM OF 1,4-BIS[1,2-BENZISOSELENAZOL-3(2H)-OH]-BUTANE, METHOD OF ITS PREPARATION AND USE |
2020 |
- Tszen, Khuejkhuej
- In, Khanvej
|
RU2810162C2 |
CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE |
2018 |
- Li, Syaolin
- Syao, Khualin
- Li, Pen
- Khe, Khajin
- Li, Vejdun
|
RU2800751C2 |
CRYSTAL AND SALT FORMS OF PPAR AGONIST COMPOUNDS |
2017 |
- Lagu, Bkharat
- Tshaska, Skott
|
RU2759724C2 |
COMPOUNDS FOR IMPROVED STEM CELL DIFFERENTIATION INTO HEPATOCYTES |
2014 |
- Chiao Erik
- Gamilton Metyu Majkl
- Kameoka Sej
- Leonard Brajan
- Triyatni Miriam
|
RU2662954C2 |
HETEROCYCLIC IMMUNOMODULATORS AS INHIBITOR OF IMMUNE RESPONSE CHECKPOINTS PDL1 |
2020 |
- Mak Gouen, Devid Krejg
- Yakobi, Edgar
|
RU2824127C2 |
CRYSTAL FORM OF PHOSPHODIESTERASE INHIBITOR, METHOD OF ITS PREPARATION AND USE |
2020 |
|
RU2814498C2 |
HEPATITIS B (HBV) INHIBITOR |
2017 |
- Ivashchenko Andrej Aleksandrovich
- Aleksandr Vasilevich Ivashchenko
- Nikolaj Filippovich Savchuk
- Boris Rogovoj
- Vadim Vasilevich Bychko
|
RU2666727C1 |
NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION |
2017 |
- Aleksandr Vasilevich Ivashchenko
- Mitkin Oleg Dmitrievich
|
RU2659388C1 |
CRYSTALLINE FORM OF SMAC MIMETIC USED AS IAP INHIBITOR, AND METHOD FOR PRODUCTION THEREOF |
2020 |
- Lyu, Inchun
- Syuj, Chzhaobin
- Khu, Likhun
- Din, Charlz Z.
- Chzhu, Sinsyun
- Chen, Shukhuej
|
RU2819398C2 |